Keywords: Parkinson's Disease, Parkinson's Disease
Motivation: Cerebello-thalamo-cortical, particularly cerebellar, GABA, Glx may influence tremor severity in Parkinson's disease, and the impact of dopaminergic medication on cerebellar levels is current unknown.
Goal(s): To measure cerebello-thalamo-cortical GABA and Glx in the OFF, and ON dopaminergic medication states in patients with PD, and ascertain the influence on tremor severity.
Approach: Single-voxel J-difference edited MRS data was acquired using MEGA-semiLASER from the dentate, thalamus and motor cortex in the OFF and ON medication states.
Results: Cerebellar Glx drives the tremor severity in PD, and dopaminergic medication produces a reduction in cerebellar Glx which in turn leads to an improvement in tremor severity.
Impact: Cerebellar Glx drives tremor severity in PD, and dopaminergic medication mediated reduction leads to an improvement in tremor severity. These results provide the first evidence of cerebellar Glx involvement in PD, and open avenues for new therapeutic interventions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords